Literature DB >> 25083051

Neurological disorders and inflammatory bowel diseases.

Giovanni Casella1, Gian Eugenio Tontini1, Gabrio Bassotti1, Luca Pastorelli1, Vincenzo Villanacci1, Luisa Spina1, Vittorio Baldini1, Maurizio Vecchi1.   

Abstract

Extraintestinal manifestations occur in about one-third of patients living with inflammatory bowel disease (IBD) and may precede the onset of gastrointestinal symptoms by many years. Neurologic disorders associated with IBD are not frequent, being reported in 3% of patients, but they often represent an important cause of morbidity and a relevant diagnostic issue. In addition, the increasing use of immunosuppressant and biological therapies for IBD may also play a pivotal role in the development of neurological disorders of different type and pathogenesis. Hence, we provide a complete and profound review of the main features of neurological complications associated with IBD, with particular reference to those related to drugs and with a specific focus on their clinical presentation and possible pathophysiological mechanisms.

Entities:  

Keywords:  Cerebrovascular diseases; Crohn’s disease; Demyelinating neuropathies; Extraintestinal manifestations; Inflammatory bowel diseases; Multiple sclerosis; Neurological disorders; Progressive multifocal encephalopathy; Side effects; Ulcerative colitis

Mesh:

Substances:

Year:  2014        PMID: 25083051      PMCID: PMC4112885          DOI: 10.3748/wjg.v20.i27.8764

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  172 in total

Review 1.  Extraintestinal manifestations in inflammatory bowel disease.

Authors:  Silvio Danese; Stefano Semeraro; Alfredo Papa; Italia Roberto; Franco Scaldaferri; Giuseppe Fedeli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

Review 2.  TNFalpha blockade in human diseases: an overview of efficacy and safety.

Authors:  Jan Lin; David Ziring; Sheetal Desai; Sungjin Kim; Maida Wong; Yael Korin; Jonathan Braun; Elaine Reed; David Gjertson; Ram Raj Singh
Journal:  Clin Immunol       Date:  2007-10-04       Impact factor: 3.969

3.  Reversible leukoencephalopathy after oral methotrexate.

Authors:  Hille Koppen; Judith A Wessels; Jaques A P M Ewals; Frank E E Treurniet
Journal:  J Rheumatol       Date:  2012-09       Impact factor: 4.666

4.  Remission of myasthenia gravis after proctocolectomy in a patient with ulcerative colitis.

Authors:  C Gower-Rousseau; D Reumaux; M Bellard; L Delecourt; M Ribet; J F Colombel
Journal:  Am J Gastroenterol       Date:  1993-07       Impact factor: 10.864

Review 5.  Ulcerative colitis associated with Takayasu's disease in two patients who received proctocolectomy.

Authors:  Hideki Masuda; Ukimoto Ishii; Nobuhiko Aoki; Hisashi Nakayama; Fumii Sato; Hideaki Karube; Shigeru Suzuki; Toshihiko Kondo
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

6.  Acute deafness as an extraintestinal manifestation of ulcerative colitis.

Authors:  Germán Morís; Ana Milla; Renee Ribacoba; Carmen González
Journal:  Eur J Intern Med       Date:  2005-10       Impact factor: 4.487

7.  Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists.

Authors:  Amer Alshekhlee; Kevian Basiri; J Douglas Miles; Saef A Ahmad; Bashar Katirji
Journal:  Muscle Nerve       Date:  2010-05       Impact factor: 3.217

Review 8.  Demyelination and inhibition of tumor necrosis factor (TNF).

Authors:  M D Magnano; W H Robinson; M C Genovese
Journal:  Clin Exp Rheumatol       Date:  2004 Sep-Oct       Impact factor: 4.473

9.  Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.

Authors:  N Mohan; E T Edwards; T R Cupps; P J Oliverio; G Sandberg; H Crayton; J R Richert; J N Siegel
Journal:  Arthritis Rheum       Date:  2001-12

10.  Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

Authors:  W Miehsler; W Reinisch; E Valic; W Osterode; W Tillinger; T Feichtenschlager; J Grisar; K Machold; S Scholz; H Vogelsang; G Novacek
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

View more
  19 in total

1.  Cognitive impairment in Crohn's disease is associated with systemic inflammation, symptom burden and sleep disturbance.

Authors:  Daniel R van Langenberg; Greg W Yelland; Stephen R Robinson; Peter R Gibson
Journal:  United European Gastroenterol J       Date:  2016-08-08       Impact factor: 4.623

Review 2.  Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives.

Authors:  Gian Eugenio Tontini; Maurizio Vecchi; Luca Pastorelli; Markus F Neurath; Helmut Neumann
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

3.  Symptomatic sensorineural hearing loss in patients with ulcerative colitis.

Authors:  G Casella; D Corbetta; M Zolezzi; C Di Bella; V Villanacci; M Salemme; U Milanesi; E Antonelli; V Baldini; G Bassotti
Journal:  Tech Coloproctol       Date:  2015-08-18       Impact factor: 3.781

Review 4.  Structural brain lesions in inflammatory bowel disease.

Authors:  Can Dolapcioglu; Hatice Dolapcioglu
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

Review 5.  The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics.

Authors:  Carlos R Camara-Lemarroy; Luanne Metz; Jonathan B Meddings; Keith A Sharkey; V Wee Yong
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

6.  Proteinase 3-antineutrophil cytoplasmic antibody-positive ulcerative colitis presenting with abducens neuropathy.

Authors:  Yuki Kirito; Daisuke Yamamoto; Tsuyoshi Uchiyama
Journal:  BMJ Case Rep       Date:  2017-01-09

7.  Patients With Inflammatory Bowel Diseases Are at Higher Risk for Meningitis.

Authors:  Bharati Kochar; Yue Jiang; Millie D Long
Journal:  J Clin Gastroenterol       Date:  2021-04-01       Impact factor: 3.174

Review 8.  Psoriasis and inflammatory bowel disease: links and risks.

Authors:  Christoforos Vlachos; Georgios Gaitanis; Konstantinos H Katsanos; Dimitrios K Christodoulou; Epameinondas Tsianos; Ioannis D Bassukas
Journal:  Psoriasis (Auckl)       Date:  2016-07-20

9.  Cerebral granulomatosis as a manifestation of Crohn's disease.

Authors:  Konrad Whittaker; Konstanze Guggenberger; Nils Venhoff; Soroush Doostkam; Hans-Eckart Schaefer; Brita Fritsch
Journal:  BMC Neurol       Date:  2018-10-03       Impact factor: 2.474

10.  Peptic ulcer does not increase the risk of dementia: A nested case control study using a national sample cohort.

Authors:  Hyo Geun Choi; Jae Seung Soh; Jae Sung Lim; Song Yong Sim; Yoon Jung Jung; Suk Woo Lee
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.